Navigation Links
Survival Data for Avicena's Amyotrophic Lateral Sclerosis Drug Candidate, AL-02, to be Presented at 18th International Symposium on ALS/MND
Date:10/18/2007

ompromised. With an incidence rate of approximately 1 in 10,000, ALS affects roughly 30,000 Americans at any given time. Each year, approximately 5,600 new cases of ALS are diagnosed. The two types of ALS are "sporadic ALS," which accounts for approximately 85% - 90% of all cases; and "familial ALS," which accounts for the remaining 10% - 15% of patients. A progressive degeneration of motor neurons eventually leads to neuron death resulting in the brain's inability to initiate or control muscle movement. Once a patient's muscles no longer receive the messages that they require to function, muscles begin to atrophy.

ABOUT AVICENA

Avicena Group, Inc. (OTC Bulletin Board: AVGO) is a Palo Alto, California based late-stage biotechnology company that develops central nervous system therapeutics for neurodegenerative diseases. The Company's core technologies, supported by a robust IP portfolio, have broad applications in both pharmaceuticals and dermaceuticals. Avicena's pharmaceutical program centers on rare neurological disorders (orphan diseases). Near term, the Company plans to initiate a confirmatory Phase III trial in ALS and a Phase III trial in Huntington's disease to accompany the ongoing NIH Phase III trial in Parkinson's disease. Avicena's science is well established and its products are safe and well tolerated. Unlike traditional biotechnology companies, Avicena's clinical programs are largely funded by government and non-profit organizations. Avicena presently derives revenue from the sale of proprietary dermaceutical ingredients to skin care manufacturers.

SAFE HARBOR

This release contains forward-looking statements that reflect, among other things, management's current expectations, plans and strategies, all of which are subject to known and unknown risks, uncertainties and factors that may cause our actual results to differ materially from those expressed or implied by these forward-looking statements. Many of these risks are beyond
'/>"/>

SOURCE Avicena Group, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Velcade (bortezomib) for Injection Based Induction Therapy Delivered High Post-Transplant Complete Remission Rate, a Critical Marker for Increased Overall Survival
2. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
3. The International Myeloma Foundation Says Data Reported at a Global Medical Meeting in Greece Demonstrates Improved Survival for a Wide Range of Myeloma Patients
4. Velcade (bortezomib) for Injection Based Therapies Achieved Survival Rates as High as 100 Percent in Newly Diagnosed Multiple Myeloma Patients
5. Velcade (bortezomib) for Injection Survival Data in Front-Line Multiple Myeloma Patients to be Featured at 11th International Myeloma Workshop
6. First single breast cancer study to show significant survival benefit for women switching from tamoxifen to Arimidex
7. Research Documents Scalable Production, Survival Following Engraftment and Positive Impact on Cardiac Function in Infarcted Rats for Gerons Human Embryonic Stem Cell-Based Therapeutic for Heart Failure
8. Anastrozole (Arimidex) Improves Overall Survival in Postmenopausal Women with Early Breast Cancer Receiving Treatment with Tamoxifen
9. Ivivis PEMF Technology Significantly Improves Neuron Survival in Parkinsons Disease Model, Study Finds
10. Synta Presents Results for STA-4783 in Metastatic Melanoma Showing Improvement in Overall Survival
11. Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III Melanoma Demonstrated Significant and Sustained Impact on Relapse-Free Survival
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... July 6, 2015  Protiviti, a global consulting firm, ... Auditing around the World publication ( www.protiviti.com/iaworld ). ... reported on the evolution of the internal audit profession ... globe as a means to providing senior executives and ... strategic business function. The 2015 edition of ...
(Date:7/6/2015)... -- Hologic, Inc. (NASDAQ: HOLX ) announced today ... for the third quarter of fiscal 2015 on Wednesday, ... with the release, management will host a conference call ... Interested participants may listen to the call by dialing ... or 719-325-4804 (for international callers) and referencing access code ...
(Date:7/6/2015)... , July 6, 2015 E-QURE Corp ... will present live at VirtualInvestorConferences.com on July 9, 2015. ... LINK: http://tinyurl.com/e-qure-presentation This will ... invited to ask the company questions in real-time - ... association,s "virtual trade booth." If attendees are not able ...
Breaking Medicine Technology:New Edition of Internal Auditing Around the World from Protiviti Explores Changes and Trends 2Hologic to Announce Financial Results for the Third Quarter of Fiscal 2015 on Wednesday, July 29, 2015 2E-QURE Corp to Webcast, Live, at VirtualInvestorConferences.com July 9 2
... ARBOR, Mich., Sept. 17 Terumo Heart, ... European Launch Symposium at the European,Association of ... (Logo: http://www.newscom.com/cgi-bin/prnh/20061027/DEF004LOGO ) (Logo: ... of the European Clinical Trial results for ...
... to enter Phase 2 clinical development, PRINCETON, ... an innovator in the discovery and development of ... a Phase 2a,clinical study of PS433540, the company,s ... and endothelin receptor antagonist,(DARA) that is being developed ...
Cached Medicine Technology:Terumo Heart Reports Summary of DuraHeart(TM) LVAS Clinical Trial Results 2Pharmacopeia Initiates Phase 2 Hypertension Study with PS433540 (DARA) 2Pharmacopeia Initiates Phase 2 Hypertension Study with PS433540 (DARA) 3Pharmacopeia Initiates Phase 2 Hypertension Study with PS433540 (DARA) 4Pharmacopeia Initiates Phase 2 Hypertension Study with PS433540 (DARA) 5
(Date:7/6/2015)... ... July 06, 2015 , ... ... $400,000 in grant funds to support a three-year effort to reduce rates of ... will be conducted in partnership with the Morehouse School of Medicine’s Prevention Research ...
(Date:7/6/2015)... ... July 06, 2015 , ... Orthopaedic & ... his 100th case using SpineFrontier’s® PedFuse® REmind® Screws. The operation took place on ... VA. The procedure was an L5-S1 posterior lumbar interbody fusion on a 69 ...
(Date:7/5/2015)... ... July 06, 2015 , ... ... market, is excited to announce the next generation of PrimeStar Individual Dental Insurance. ... to now include two network options—Maximum Allowable Charge (MAC) and usual, customary and ...
(Date:7/5/2015)... ... 2015 , ... Women’s Excellence in Wellness, powered by Movestrong is ... special consists of 2 months of unlimited classes for just $65. Student ID is ... 1410 South Lapeer Road in Lake Orion. , Women’s Excellence is ...
(Date:7/4/2015)... NY (PRWEB) , ... July 04, 2015 , ... Chronic ... 15% of chronic pain sufferers have pain located in the neck. Another 19% suffer ... the neck. Chiropractic literature suggests that 45% of American workers must deal ...
Breaking Medicine News(10 mins):Health News:Georgia State, Morehouse Partner To Tackle Diabetes, Heart Disease In Atlanta’s Minority Communities 2Health News:100th Outpatient Less Exposure Surgery Procedure Completed by Industry Leading Surgeon Dr. Jeffrey Carlson 2Health News:100th Outpatient Less Exposure Surgery Procedure Completed by Industry Leading Surgeon Dr. Jeffrey Carlson 3Health News:Security Life Insurance Company of America Launches the Next Generation of PrimeStar Individual Dental Insurance Plans 2Health News:New Advancement in Treatment of Chronic Neck Pain 2Health News:New Advancement in Treatment of Chronic Neck Pain 3
... Moms and Babies, Bad for Mercury Fear,Campaign, WASHINGTON, ... for pregnant women, issued this morning by,the National Healthy ... at the nonprofit Center for Consumer Freedom,made the following ... and mercury swung back in the,direction of common sense. ...
... a departure from,current FDA and EPA guidelines, an ... childbearing age to increase their seafood,consumption, despite the ... other contaminants commonly found in seafood., "It,s ... fish without,mentioning the documented public health risks associated ...
... PRINCETON, N.J., Oct. 4 The following is a,statement ... their health information online:, It is encouraging that ... develop personal health record (PHR) products and systems,that people ... we,hope more companies will follow suit. Having ready access ...
... fired for managing diabetes at work but whose ... before House Judiciary,Subcommittee about his experience, ALEXANDRIA, ... reiterated its strong support for the ADA,Restoration Act, ... landmark,1990 Americans with Disabilities Act. On Thursday, the ...
... Psychemedics Corporation,(AMEX: PMD ) today announced that ... Controller. Jennifer will be responsible for all ... the financial analysis and planning,activities necessary for the ... Chairman and CEO. Since 1999, Jennifer has ...
... My Diabetes Connector, provides patients with virtual diabetes health- ... ... The American,Diabetes Association today unveiled a new web-based diabetes tool ... care providers -- to,share and organize important health information to ...
Cached Medicine News:Health News:Consumer Group Statement on Seafood and Health: 'We Told You So' 2Health News:Statement Regarding Microsoft's Announcement of New Services to Help People Store Their Health Information Online 2Health News:American Diabetes Association Urges Congress to Pass ADA Restoration Act, Help End Employment Discrimination Against Americans with Diabetes 2Health News:American Diabetes Association Urges Congress to Pass ADA Restoration Act, Help End Employment Discrimination Against Americans with Diabetes 3Health News:Jennifer Chmieleski Joins Psychemedics Corporation as Top Financial Officer 2Health News:New Diabetes Tool Available on American Diabetes Association Web Site 2Health News:New Diabetes Tool Available on American Diabetes Association Web Site 3Health News:New Diabetes Tool Available on American Diabetes Association Web Site 4
3.2% Tryptone, 2.0% Yeast Extract, 0.5% Sodium Chloride, pH 7.5....
For connection to the bipolar output of electrosurgical generators....
This table has an adjustable height, two legs, and square post. Clamps and standard 1" (2.5 cm) pad included....
... for orthopedic procedures. Molded armrests ... 24" for the surgeon's comfort. ... to any O.R. table. Split ... and stability. Optional post or ...
Medicine Products: